Mineralys Therapeutics, Inc. (MLYS)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

($2.98M) Net Amount

Buy:	$7.50M	$13.50
Sell:	($10.48M)	$11.99 - $13.57

Company Sentiment

Other

Other

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

1

(3)

2

(2)

0

(1)

1

0

3

+1

0

+2

1

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
15-Oct-24 4:22 PM View:	14-Oct-24 Option Exercise $5.78K	Rodman David Malcom Chief Medical Officer		Mineralys Therapeutics, Inc. - MLYS	803% 15.05K to 135.97K	0	0	--	--	Show Txns Hide Txns

15-Oct-24 4:21 PM View:	11-Oct-24 Market Sale (Planned) ($206.43K)	Congleton Jon Chief Executive Officer Director		Mineralys Therapeutics, Inc. - MLYS	(15%) 1.05M to 895.94K	0	($1.76M) (13%)	--	$11.99 - $13.52	Show Txns Hide Txns

14-Feb-24 9:07 PM View:	12-Feb-24 Grant $7.50M	Akkaraju Srinivas Director 10% Owner		Mineralys Therapeutics, Inc. - MLYS	12% 4.52M to 5.07M	0	0	--	--	Show Txns Hide Txns

26-Jul-24 9:45 PM View:	24-Jul-24 Market Sale ($7.18M)	Slingsby Brian Taylor Director 10% Owner		Mineralys Therapeutics, Inc. - MLYS	(6%) 9.19M to 8.64M	0	($7.18M) (6%)	--	$13.05	Show Txns Hide Txns

14-Feb-24 7:49 PM View:	12-Feb-24 Grant $22.58M	Ra Capital Management, LLC Director		Mineralys Therapeutics, Inc. - MLYS	53% 3.18M to 4.85M	0	0	--	--	Show Txns Hide Txns

15-Oct-24 4:22 PM View:	11-Oct-24 Market Sale (Planned) ($146.00K)	Levy Adam Scott CFO and Secretary		Mineralys Therapeutics, Inc. - MLYS	(33%) 352.28K to 236.85K	0	($1.54M) (34%)	--	$12.94 - $13.57	Show Txns Hide Txns

14-Feb-24 9:06 PM View:	12-Feb-24 Market Purchase $7.50M	Samsara Biocapital Gp, LLC 10% Owner		Mineralys Therapeutics, Inc. - MLYS	12% 4.52M to 5.07M	$7.50M 12%	0	$13.50	--	Show Txns Hide Txns